FR2500831A1 - Nouvelles n-aryl-oxazolidinones et -pyrrolidinones - Google Patents

Nouvelles n-aryl-oxazolidinones et -pyrrolidinones Download PDF

Info

Publication number
FR2500831A1
FR2500831A1 FR8103954A FR8103954A FR2500831A1 FR 2500831 A1 FR2500831 A1 FR 2500831A1 FR 8103954 A FR8103954 A FR 8103954A FR 8103954 A FR8103954 A FR 8103954A FR 2500831 A1 FR2500831 A1 FR 2500831A1
Authority
FR
France
Prior art keywords
sep
group
formula
hydroxymethyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8103954A
Other languages
English (en)
French (fr)
Other versions
FR2500831B1 (US06582424-20030624-M00016.png
Inventor
Jean-Francois Ancher
Guy Bourgery
Philippe Dostert
Colette Douzon
Patrick Guerret
Alain Lacour
Michel Langlois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Priority to FR8103954A priority Critical patent/FR2500831A1/fr
Publication of FR2500831A1 publication Critical patent/FR2500831A1/fr
Application granted granted Critical
Publication of FR2500831B1 publication Critical patent/FR2500831B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8103954A 1981-02-27 1981-02-27 Nouvelles n-aryl-oxazolidinones et -pyrrolidinones Granted FR2500831A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8103954A FR2500831A1 (fr) 1981-02-27 1981-02-27 Nouvelles n-aryl-oxazolidinones et -pyrrolidinones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8103954A FR2500831A1 (fr) 1981-02-27 1981-02-27 Nouvelles n-aryl-oxazolidinones et -pyrrolidinones

Publications (2)

Publication Number Publication Date
FR2500831A1 true FR2500831A1 (fr) 1982-09-03
FR2500831B1 FR2500831B1 (US06582424-20030624-M00016.png) 1984-02-24

Family

ID=9255695

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8103954A Granted FR2500831A1 (fr) 1981-02-27 1981-02-27 Nouvelles n-aryl-oxazolidinones et -pyrrolidinones

Country Status (1)

Country Link
FR (1) FR2500831A1 (US06582424-20030624-M00016.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026827A1 (en) * 2002-09-20 2004-04-01 F. Hoffmann-La Roche Ag Pyrrolidone derivatives as maob inhibitors
US7173023B2 (en) 2003-10-23 2007-02-06 Hoffmann-La Roche Inc. Bicyclic compounds

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004026827A1 (en) * 2002-09-20 2004-04-01 F. Hoffmann-La Roche Ag Pyrrolidone derivatives as maob inhibitors
WO2004026825A1 (en) * 2002-09-20 2004-04-01 F.Hoffmann-La Roche Ag Pyrrolidone derivatives as maob inhibitors
WO2004026826A1 (en) * 2002-09-20 2004-04-01 F. Hoffmann-La Roche Ag 4-pyrrolidino-phenyl-benzyl ether derivatives
US7037935B2 (en) 2002-09-20 2006-05-02 Hoffmann-La Roche Inc. 4-Pyrrolidino-phenyl-benzyl ether derivatives
US7122562B2 (en) 2002-09-20 2006-10-17 Hoffmann-La Roche Inc. 4-pyrrolidino-phenyl-benzyl ether derivatives
US7151111B2 (en) 2002-09-20 2006-12-19 Hoffmann-La Roche Inc. 4-pyrrolidino-phenyl-benzyl ether derivatives
US7235581B2 (en) 2002-09-20 2007-06-26 Hoffman-La Roche Inc. 4-pyrrolidino-phenyl-benzyl ether derivatives
CN100383118C (zh) * 2002-09-20 2008-04-23 弗·哈夫曼-拉罗切有限公司 4-吡咯烷基-苯基-苄基醚衍生物
CN100400509C (zh) * 2002-09-20 2008-07-09 弗·哈夫曼-拉罗切有限公司 作为maob抑制剂的吡咯烷酮衍生物
AU2003273901B2 (en) * 2002-09-20 2008-07-10 F. Hoffmann-La Roche Ag 4-pyrrolidino-phenyl-benzyl ether derivatives
HRP20050263B1 (hr) * 2002-09-20 2013-09-30 F. Hoffmann - La Roche Ag Derivati pirolidina kao inhibitori maob
US7173023B2 (en) 2003-10-23 2007-02-06 Hoffmann-La Roche Inc. Bicyclic compounds

Also Published As

Publication number Publication date
FR2500831B1 (US06582424-20030624-M00016.png) 1984-02-24

Similar Documents

Publication Publication Date Title
CA1113093A (fr) Hydroxymethyl-5 oxazolidinones-2, leur procede de preparation et leur application therapeutique
CH642069A5 (fr) N-aryle oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines et thiazolidinones, leurs procedes de preparation, et medicaments les contenant.
FR2500450A1 (fr) Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
EP0040591A1 (fr) Dérivés de pyridoxine, leur procédé de préparation ainsi que leur utilisation en thérapeutique
CH618975A5 (US06582424-20030624-M00016.png)
EP0424243A1 (fr) Dérivés d'aryl-3 oxazolidinone, leur procédé de préparation et leur application en thérapeutique
CH650780A5 (fr) N-aryl oxazolidinones-2, leur procede de preparation et composition pharmaceutique les contenant.
FR2458547A2 (fr) Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique
CA1258040A (fr) 2-amino oxazolines et leur procede d'obtention
EP0122827B1 (fr) (Carbéthoxy-2 benzalkylamido-4 phénoxy)-1 amino-3 propanols-2, leurs préparations et leurs utilisations en thérapeutique
EP0004494A1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
FR2500831A1 (fr) Nouvelles n-aryl-oxazolidinones et -pyrrolidinones
FR2506769A2 (fr) Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
EP0294258A1 (fr) Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant
EP0100257B1 (fr) Nouveaux dérivés aminoalkyl naphtaléniques, leurs sels d'addition d'acide et le procédé de préparation ainsi que l'application en thérapeutique de ces dérivés et sels
EP0022407B1 (fr) Cyclophosphathiazènes, procédé pour leur préparation et compositions les contenant
FR2508032A1 (fr) Nouveaux derives amino-3 aryloxymethyl-2 propanol-1, leur procede de preparation et leurs applications en therapeutique
FR2545488A1 (fr) Nouveaux carbamates cycliques a chaine laterale du type arylmethyle ou aryloxymethyle, leurs procedes de preparation et leur application en therapeutique
EP0022710B1 (fr) Procédé d'obtention de benzodiazépines-1,4
FR2552085A1 (fr) Derives condenses d'as-triazine et compositions pharmaceutiques les contenant
FR2460940A2 (fr) Nouvelles hydroxymethyl-5 oxazolidinones-2, leur procede de preparation et leur application en therapeutique
FR2625503A1 (fr) Derives de dioxazocine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2504141A1 (fr) Nouveaux derives dioxazabicycliques, leur procede de preparation et leur application en therapeutique
FR2462434A1 (fr) Nouveaux derives de benzo(b)furanne et compositions pharmaceutiques contenant ces derives
EP0007843A1 (fr) Dérivés de propiophénone, leur application en thérapeutique et leur préparation

Legal Events

Date Code Title Description
ST Notification of lapse